Associations between Serum Kallistatin Levels and Markers of Glucose Homeostasis, Inflammation, and Lipoprotein Metabolism in Patients with Type 2 Diabetes and Nondiabetic Obesity
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25116264 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hajnalka Lőrincz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Serpins, Obesity, Biomarkers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office - NKFIH, Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund, Eötvös Loránd Research Network.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kallistatin is an endogenous serine proteinase inhibitor with various functions, including antioxidative, anti-inflammatory, and anti-atherosclerotic properties. To date, associations between kallistatin and lipoprotein subfractions are poorly investigated. In this study, we enrolled 62 obese patients with type 2 diabetes (T2D), 106 nondiabetic obese (NDO) subjects matched in gender, age, and body mass index, as well as 49 gender- and age-matched healthy, normal-weight controls. Serum kallistatin levels were measured with ELISA, and lipoprotein subfractions were analyzed using Lipoprint® (Quantimetrix Corp., Redondo Beach, CA, USA) gel electrophoresis. Kallistatin concentrations were significantly higher in T2D patients compared to NDO and control groups. We found significant positive correlations between very-low-density lipoprotein (VLDL), small high-density lipoprotein (HDL) subfractions, glucose, hemoglobin A1c (HbA1c), betatrophin, and kallistatin, while negative correlations were detected between mean low-density lipoprotein (LDL) size, large and intermediate HDL subfractions, and kallistatin in the whole study population. The best predictor of kallistatin was HbA1c in T2D patients, high-sensitivity C-reactive protein (hsCRP) and betatrophin in NDO patients, and hsCRP in controls. Our results indicate that kallistatin expression might be induced by persistent hyperglycemia in T2D, while in nondiabetic subjects, its production might be associated with systemic inflammation. The correlation of kallistatin with lipid subfractions may suggest its putative role in atherogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
- Doctoral School of Health Sciences, University of Debrecen, H-4032 Debrecen, Hungary.
- Department of Emergency Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.
- Institute of Health Studies, Faculty of Health Sciences, University of Debrecen, H-4032 Debrecen, Hungary.
- ELKH-UD Vascular Pathophysiology Research Group 11003, University of Debrecen, H-4032 Debrecen, Hungary.
ORCID-Profile: Hajnalka Lőrincz, Balázs Ratku, Mariann Harangi
Förderung
- National Research, Development and Innovation Office - NKFIH
- Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund
- Eötvös Loránd Research Network
- National Research, Development, and Innovation Office—NKFIH
- Ministry of Innovation and Technology of Hungary
- National Research, Development, and Innovation Fund
Zitieren
APA
Lőrincz, H., Csiha, S., Ratku, B., Somodi, S., Sztanek, F., Paragh, G., & Harangi, M. (2024). Associations between Serum Kallistatin Levels and Markers of Glucose Homeostasis, Inflammation, and Lipoprotein Metabolism in Patients with Type 2 Diabetes and Nondiabetic Obesity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116264
Vancouver
Lőrincz H, Csiha S, Ratku B, Somodi S, Sztanek F, Paragh G, et al. Associations between Serum Kallistatin Levels and Markers of Glucose Homeostasis, Inflammation, and Lipoprotein Metabolism in Patients with Type 2 Diabetes and Nondiabetic Obesity. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25116264
BibTeX
@article{Lrincz2024,
author = {Lőrincz, Hajnalka and Csiha, Sára and Ratku, Balázs and Somodi, Sándor and Sztanek, Ferenc and Paragh, György and Harangi, Mariann},
title = {Associations between Serum Kallistatin Levels and Markers of Glucose Homeostasis, Inflammation, and Lipoprotein Metabolism in Patients with Type 2 Diabetes and Nondiabetic Obesity},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25116264}
}
EUVIMED